Resource Page

Choosing Wisely and the climate crisis: a role for clinicians

Quality and Safety in Health Care Journal -

There are growing calls for healthcare to confront it’s role in the climate crisis. Estimates suggest that carbon emissions from healthcare constitute 5% of net global emissions. To put this into context, emissions from all air travel are estimated at 3.5% of net global emissions.1 Health systems, organisations and clinicians have been called on to lead efforts to reduce emissions given that the climate crisis presents a major threat to human health.

Ensuring appropriateness of care, and reducing overuse are central planks of strategies suggested in the literature and are increasingly being enacted by large healthcare systems and provider organisations to reduce healthcare’s climate impact.2 However, individual clinicians are often left with little guidance or support in terms of how to do this in practice. To illustrate, the Agency for Health Care Research and Quality (AHRQ) within the United States Department of Health and Human...

Is targeting healthcares carbon footprint really the best we can do to help address the climate crisis?

Quality and Safety in Health Care Journal -

I write this commentary as wildfires rage around the world, including in Greece, Italy, Siberia, Algeria and the USA. In my own country, Canada, fires have already consumed over 130 000 km21—the size of Greece—and the wildfire season has not yet ended. Recent months have also seen hundreds of millions of people suffering scorching heatwaves across Europe, China and North America. Residents of Phoenix, Arizona, endured temperatures over 43°C for 31 consecutive days this summer. In Italy, harsh heat in the south occurred at the same time as storms delivered hail the size of tennis balls in the country’s north. This almost ‘end of days’ juxtaposition of extreme weather events within a single country comes as new research indicates that the Gulf Stream may collapse as soon as 2025.1 Loss of these vital ocean currents would constitute a climate tipping point, making extreme storms more frequent...

Today The World Issues Voluntary Nationwide Recall of All Lots of Sustain and Schwinnng brand Dietary Supplement Capsules Due to the Presence of Undeclared Tadalafil and Nortadalafil

FDA MedWatch -

“Today The World” is voluntarily recalling two lots of Sustain herbal dietary supplement capsules and one lot of Schwinnng capsules to the consumer level. FDA analysis has found the products to contain undeclared Tadalafil and Nortadalafil (structurally similar to Tadalafil). Tadalafil and Nortadala

Today The World Issues Voluntary Nationwide Recall of All Lots of Arize Herbal Dietary Supplement Capsules Due to the Presence of Undeclared Nortadalafil

FDA MedWatch -

“Today The World” is voluntarily recalling one lot of Arize Herbal Dietary Supplement capsules to the consumer level.
FDA analysis has found the products to contain undeclared Nortadalafil (structurally similar to Tadalafil). Nortadalafil is an active drug ingredient known for treatment of male ere

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Due to the Presence of Benzene

FDA MedWatch -

Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid to the consumer level. A recent review by our manufacturer and their third-party lab found that samples from two lot

Azurity Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Zenzedi® (dextroamphetamine sulfate tablets, USP) 30 mg Due to a Mislabeled Package During Manufacturing

FDA MedWatch -

Woburn, Massachusetts, Azurity Pharmaceuticals, Inc. is voluntarily recalling one (1) lot (F230169A) of Zenzedi® CII (dextroamphetamine sulfate tablets, USP) 30 mg to the consumer level. The product is being recalled due to a report from a pharmacist in Nebraska who opened a bottle of Zenzedi® 30 m

Haleon Issues Voluntary Nationwide Recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult Products Due to Microbial Contamination

FDA MedWatch -

Haleon is voluntarily recalling eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult to the consumer level. The product is being recalled due to microbial contamination. In immunocompromised individuals, the use of the affected product could potentially result

Windstone Medical Packaging dba Aligned Medical Solutions Issues Nationwide Recall of Nurse Assist Sterile Saline Placed Into the Following Kits; AMS10833 Local Lower Extremity Pack I, AMS12947 In House Ocular Pack, AMS12947A In House Ocular Pack and...

FDA MedWatch -

On December 22, 2023, Aligned Medical Solutions, Billings, MT, initiated a nationwide recall of Nurse Assist Sterile Saline packaged into medical device kits including AMS10833 Local Lower Extremity Pack I, AMS12947 In House Ocular Pack, AMS12947A In House Ocular Pack and AMS13043 Closure Kit. Produ

Pages

Subscribe to Medication Safety Officers Society- MSOS aggregator - Resource Page